To confirm the role of METTL14 in vivo, tumour xenograft models were constructed by subcutaneously injecting HCC cells (HCCLM3) with either stable overexpression of wide‐type METTL14 or METTL14‐R298P mutant into nude mice. The gene discussed is METTL14; the disease is hepatocellular carcinoma.